{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01375",
      "entity_text" : "TNF-alpha",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:53481793",
      "entity_text" : "LPS",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "AGK2 treatment significantly decreased the LPS induced TNF-alpha and IL-6 production (TNF-alpha : 23.9 +/-2.8 vs 68.1 +/-6.4 pg/ml, p = 0.0009; IL-6 : 49.6 +/-3.0 vs 73.1 +/-4.2 pg/ml; p = 0.0051; Fig. XREF_FIG).",
  "reading_complete" : "2020-07-28T11:30:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T11:27:28Z",
  "trigger" : "induced",
  "evidence" : [ "LPS-induced TNF-alpha" ],
  "pmc_id" : "4824319",
  "score" : 0
}